SOX4 and pancreatic neoplasm: Instead, our study suggests one possible epigenetic modification mechanism for SOX4 expression in pancreatic cancer via repressed expression level of miR-129-2 and miR-335, which would otherwise target SOX4 transcript at its 3′ UTR for degradation [17], [50].